Abstract:Farnesyltransferase (FTase) catalyzes the transfer of farnesyl front farnesyl diphosphate (FPP) to cysteine residues at or near the C-terminus of protein acceptors with a CaaX motif (a, aliphatic, X, Met). Farnesylation is a critical modification to many switch proteins involved ill the extracellular signal transduction pathway, which facilitates their fixation on the cell membrane where the extracellular signal is processed. The malfunction caused by mutations in these proteins often Causes uncontrolled cell reproduction and leads to tumor formation. FTase inhibitors have been extensively Studied as potential anticancer agents in recent years, several of which have advanced to different phases of clinical trials. However, the mechanism of this biologically important enzyme has not been firmly established. Understanding how FTase recruits the FPP substrate is the first and foremost step toward further mechanistic investigations and the design of effective FTase inhibitors. Molecular dynamic simulations were carried out on the tertiary structure of FTase complexed with the FPP Substrate and an acetyl-capped tetrapeptide (acetyl-CVIM), which revealed that the FPP Substrate maintains all inactive conformation and the binding of the diphosphate group call be largely attributed to residues R291 beta, K164 alpha, K294 beta, and H248 beta. The FPP Substrate assumes an extended conformation in the binding site with restricted rotation of the backbone dihedral angles; however, it does not have a well-defined conformation When unbound in Solution. This is evident from multinanosecond MID simulations of the FPP substrate in a vacuum and Solution. Our conclusion is further Supported by theoretical J Coupling calculations. Our results oil the FPP binding are in good agreement with previous experimental kinetic Studies on FTase Mutants. The hypothetical conformational activation of the FPP Substrate is currently under investigation.

Homology Modeling and Docking Studies of Furcatin Hydrolase

Homology Modelling and Molecular Dynamics Study of Human Fatty Acid Amide Hydrolase

Homology Modeling and Docking Studies of Novel alpha/beta Hydrolase Fold Proteins W14 and W15

Homology Modeling of P-Hydroxymandelate Synthase and Its Molecular Docking with Substrate

Homology Modeling and Docking Studies of Homoserine Transsuccinylase from Escherichia Coli

Docking, MD Simulations, and DFT Calculations: Assessing W254's Function and Sartan Binding in Furin

Homology modeling of a fumonisin B1 specific scFv antibody and simulation study of molecular docking between the scFv antibody and its antigen

Conformational Analyses of A Partially-Folded Bioactive Prodomain of Human Furin

Molecular Modeling Studies on Phosphonic Acid-Containing Thiazole Derivatives: Design for Fructose-1,6-bisphosphatase Inhibitors

Analysis of a Three-Dimensional Structure of Human Acidic Mammalian Chitinase Obtained by Homology Modeling and Ligand Binding Studies

Pharmacophore Modeling and Virtual Screening for the Discovery of New Fatty Acid Amide Hydrolase Inhibitors

Homology modeling of human acrosin and its molecular docking study with KF950

A Mutant T1 Lipase Homology Modeling, and Its Molecular Docking and Molecular Dynamics Simulation with Fatty Acids

Crystal Structures of Cg1458 Reveal a Catalytic Lid Domain and a Common Catalytic Mechanism for the FAH Family

Molecular Docking of Bacillus Pumilus Xylanase and Xylan Substrate Using Computer Modeling

Homology Modeling and Molecular Docking of Xylitol Dehydrogenase from Aspergillus Oryzae

Homology Modeling and Substrate Binding Study of Nudix Hydrolase Ndx1 from Thermos Thermophilus HB8.

Homology Modeling of Three-Dimensional Structure of Dimethylarginine Dimethylaminohydrolase-2(Ddah-2)and Docking Study on Ligand

Probing the Interaction Between Selected Furan Derivatives and Porcine Myofibrillar Proteins by Spectroscopic and Molecular Docking Approaches.

Analysis of the sequence and homology modeling from Bacillus fordii MH602

Computational studies of the farnesyltransferase ternary complex part I: substrate binding.